Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

LGP2 binds to PACT to regulate RIG-I- and MDA5-mediated antiviral responses.

Sanchez David RY, Combredet C, Najburg V, Millot GA, Beauclair G, Schwikowski B, Léger T, Camadro JM, Jacob Y, Bellalou J, Jouvenet N, Tangy F, Komarova AV.

Sci Signal. 2019 Oct 1;12(601). pii: eaar3993. doi: 10.1126/scisignal.aar3993.

PMID:
31575732
2.

Recombinant measles vaccine expressing malaria antigens induces long-term memory and protection in mice.

Mura M, Ruffié C, Combredet C, Aliprandini E, Formaglio P, Chitnis CE, Amino R, Tangy F.

NPJ Vaccines. 2019 Feb 27;4:12. doi: 10.1038/s41541-019-0106-8. eCollection 2019.

3.

Strong antigen-specific T-cell immunity induced by a recombinant human TERT measles virus vaccine and amplified by a DNA/viral vector prime boost in IFNAR/CD46 mice.

Pliquet E, Ruffie C, Escande M, Thalmensi J, Najburg V, Combredet C, Bestetti T, Julithe M, Liard C, Huet T, Wain-Hobson S, Tangy F, Langlade-Demoyen P.

Cancer Immunol Immunother. 2019 Apr;68(4):533-544. doi: 10.1007/s00262-018-2272-3. Epub 2019 Jan 17.

PMID:
30656384
4.

hCD46 receptor is not required for measles vaccine Schwarz strain replication in vivo: Type-I IFN is the species barrier in mice.

Mura M, Ruffié C, Billon-Denis E, Combredet C, Tournier JN, Tangy F.

Virology. 2018 Nov;524:151-159. doi: 10.1016/j.virol.2018.08.014. Epub 2018 Sep 7.

5.

DI-tector: defective interfering viral genomes' detector for next-generation sequencing data.

Beauclair G, Mura M, Combredet C, Tangy F, Jouvenet N, Komarova AV.

RNA. 2018 Oct;24(10):1285-1296. doi: 10.1261/rna.066910.118. Epub 2018 Jul 16.

6.

Nonencapsidated 5' Copy-Back Defective Interfering Genomes Produced by Recombinant Measles Viruses Are Recognized by RIG-I and LGP2 but Not MDA5.

Mura M, Combredet C, Najburg V, Sanchez David RY, Tangy F, Komarova AV.

J Virol. 2017 Sep 27;91(20). pii: e00643-17. doi: 10.1128/JVI.00643-17. Print 2017 Oct 15.

7.

Yeast lysates carrying the nucleoprotein from measles virus vaccine as a novel subunit vaccine platform to deliver Plasmodium circumsporozoite antigen.

Jacob D, Ruffie C, Combredet C, Formaglio P, Amino R, Ménard R, Tangy F, Sala M.

Malar J. 2017 Jun 29;16(1):259. doi: 10.1186/s12936-017-1908-7.

8.

Oncolytic measles virus induces tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by human myeloid and plasmacytoid dendritic cells.

Achard C, Guillerme JB, Bruni D, Boisgerault N, Combredet C, Tangy F, Jouvenet N, Grégoire M, Fonteneau JF.

Oncoimmunology. 2016 Nov 18;6(1):e1261240. doi: 10.1080/2162402X.2016.1261240. eCollection 2017.

9.

Modulation of the Type I Interferon Response Defines the Sensitivity of Human Melanoma Cells to Oncolytic Measles Virus.

Allagui F, Achard C, Panterne C, Combredet C, Labarrière N, Dréno B, Elgaaied AB, Pouliquen D, Tangy F, Fonteneau JF, Grégoire M, Boisgerault N.

Curr Gene Ther. 2017;16(6):419-428. doi: 10.2174/1566523217666170102110502.

PMID:
28042780
10.

Comparative analysis of viral RNA signatures on different RIG-I-like receptors.

Sanchez David RY, Combredet C, Sismeiro O, Dillies MA, Jagla B, Coppée JY, Mura M, Guerbois Galla M, Despres P, Tangy F, Komarova AV.

Elife. 2016 Mar 24;5:e11275. doi: 10.7554/eLife.11275.

11.

Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response.

Achard C, Boisgerault N, Delaunay T, Roulois D, Nedellec S, Royer PJ, Pain M, Combredet C, Mesel-Lemoine M, Cellerin L, Magnan A, Tangy F, Grégoire M, Fonteneau JF.

Oncotarget. 2015 Dec 29;6(42):44892-904. doi: 10.18632/oncotarget.6285.

12.

Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein.

Escriou N, Callendret B, Lorin V, Combredet C, Marianneau P, Février M, Tangy F.

Virology. 2014 Mar;452-453:32-41. doi: 10.1016/j.virol.2014.01.002. Epub 2014 Jan 28.

13.

Whole Pichia pastoris yeast expressing measles virus nucleoprotein as a production and delivery system to multimerize Plasmodium antigens.

Jacob D, Ruffie C, Dubois M, Combredet C, Amino R, Formaglio P, Gorgette O, Pehau-Arnaudet G, Guery C, Puijalon O, Barale JC, Ménard R, Tangy F, Sala M.

PLoS One. 2014 Jan 27;9(1):e86658. doi: 10.1371/journal.pone.0086658. eCollection 2014.

14.

A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus.

Brandler S, Ruffié C, Combredet C, Brault JB, Najburg V, Prevost MC, Habel A, Tauber E, Desprès P, Tangy F.

Vaccine. 2013 Aug 12;31(36):3718-25. doi: 10.1016/j.vaccine.2013.05.086. Epub 2013 Jun 4.

PMID:
23742993
15.

Identification of RNA partners of viral proteins in infected cells.

Komarova AV, Combredet C, Sismeiro O, Dillies MA, Jagla B, Sanchez David RY, Vabret N, Coppée JY, Vidalain PO, Tangy F.

RNA Biol. 2013 Jun;10(6):944-56. doi: 10.4161/rna.24453. Epub 2013 Apr 1.

16.

Natural oncolytic activity of live-attenuated measles virus against human lung and colorectal adenocarcinomas.

Boisgerault N, Guillerme JB, Pouliquen D, Mesel-Lemoine M, Achard C, Combredet C, Fonteneau JF, Tangy F, Grégoire M.

Biomed Res Int. 2013;2013:387362. doi: 10.1155/2013/387362. Epub 2013 Mar 17.

17.

Measles virus vaccine-infected tumor cells induce tumor antigen cross-presentation by human plasmacytoid dendritic cells.

Guillerme JB, Boisgerault N, Roulois D, Ménager J, Combredet C, Tangy F, Fonteneau JF, Gregoire M.

Clin Cancer Res. 2013 Mar 1;19(5):1147-58. doi: 10.1158/1078-0432.CCR-12-2733. Epub 2013 Jan 21.

18.

Measles vaccine expressing the secreted form of West Nile virus envelope glycoprotein induces protective immunity in squirrel monkeys, a new model of West Nile virus infection.

Brandler S, Marianneau P, Loth P, Lacôte S, Combredet C, Frenkiel MP, Desprès P, Contamin H, Tangy F.

J Infect Dis. 2012 Jul 15;206(2):212-9. doi: 10.1093/infdis/jis328. Epub 2012 May 2.

PMID:
22551814
19.

Proteomic analysis of virus-host interactions in an infectious context using recombinant viruses.

Komarova AV, Combredet C, Meyniel-Schicklin L, Chapelle M, Caignard G, Camadro JM, Lotteau V, Vidalain PO, Tangy F.

Mol Cell Proteomics. 2011 Dec;10(12):M110.007443. doi: 10.1074/mcp.M110.007443. Epub 2011 Sep 12.

20.

A chimeric measles virus with a lentiviral envelope replicates exclusively in CD4+/CCR5+ cells.

Mourez T, Mesel-Lemoine M, Combredet C, Najburg V, Cayet N, Tangy F.

Virology. 2011 Oct 25;419(2):117-25. doi: 10.1016/j.virol.2011.08.007. Epub 2011 Sep 3.

21.

Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic.

Guerbois M, Moris A, Combredet C, Najburg V, Ruffié C, Février M, Cayet N, Brandler S, Schwartz O, Tangy F.

Virology. 2009 May 25;388(1):191-203. doi: 10.1016/j.virol.2009.02.047. Epub 2009 Apr 5.

22.

Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus.

Brandler S, Lucas-Hourani M, Moris A, Frenkiel MP, Combredet C, Février M, Bedouelle H, Schwartz O, Desprès P, Tangy F.

PLoS Negl Trop Dis. 2007 Dec 12;1(3):e96.

23.

A paediatric vaccination vector based on live attenuated measles vaccine.

Lorin C, Combredet C, Labrousse V, Mollet L, Desprès P, Tangy F.

Therapie. 2005 May-Jun;60(3):227-33. Review.

PMID:
16128264
24.

A chimeric human T cell leukemia virus type I bearing a deltaR Moloney-murine leukemia virus envelope infects mice persistently and induces humoral and cellular immune responses.

Delebecque F, Combredet C, Gabet AS, Wattel E, Brahic M, Tangy F.

J Infect Dis. 2005 Jan 15;191(2):255-63. Epub 2004 Dec 15.

PMID:
15609236
25.

Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.

Desprès P, Combredet C, Frenkiel MP, Lorin C, Brahic M, Tangy F.

J Infect Dis. 2005 Jan 15;191(2):207-14. Epub 2004 Dec 10.

PMID:
15609230
27.

A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice.

Combredet C, Labrousse V, Mollet L, Lorin C, Delebecque F, Hurtrel B, McClure H, Feinberg MB, Brahic M, Tangy F.

J Virol. 2003 Nov;77(21):11546-54.

Supplemental Content

Loading ...
Support Center